Objective: To update and expand The North American Menopause Society’s evidence-based position on nonhormonal management of menopause-associated vasomotor symptoms (VMS), previously a portion of ...

These recommendations are based on the evidence reviewed ( Table 4). Because most trials were between 8 and 24 weeks’ duration, data on long-term use are limited. Considerations when stopping or ...